Skip to Content

Join the 'Condylomata Acuminata' group to help and get support from people like you.

Condylomata Acuminata News

Related terms: Genital Warts, Condyloma, Venereal Warts

2 Doses of HPV Vaccine Effective for Younger Teens

Posted 13 days ago by Drugs.com

TUESDAY, Nov. 22, 2016 – New global research confirms that two doses of the vaccine for HPV, rather than three, can protect younger teens against the sexually transmitted virus. Based on this study and others, U.S. government health officials revised their guidelines last month to recommend a two-dose regimen for teens younger than 15. Prior to that revised guideline, three doses were recommended for adolescents and young adults up through 26 years of age. The vaccine protects against infection by HPV (human papillomavirus), which is the cause of 90 percent of cervical cancers, according to the U.S. National Cancer Institute. The new review included more than 1,500 young people, aged 9 to 26, who were vaccinated against HPV at 52 sites in 15 countries. For the study, the researchers gave two doses of HPV vaccine to teens aged 9 to 14, and three doses of the vaccine to older teens and ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Anal Cancer Rates Rising in Many Parts of the World

Posted 2 Nov 2016 by Drugs.com

WEDNESDAY, Nov. 2, 2016 – Anal cancer rates are on the rise in many countries. But vaccination against human papillomavirus (HPV) – a virus linked to the development of anal cancer – may help curb rates of the disease, a new study suggests. Researchers looked at data from the International Agency for Research on Cancer. The data included 18 countries. The investigators found that anal cancer rates have been increasing in women and men in 13 of those countries, particularly Australia and other countries in the Americas, and northern and western Europe. In those countries, a major subtype called anal squamous cell carcinoma (ASCC) was much more common than others, and was the main reason for the overall increasing rates of anal cancer. Rates of another major subtype, anal adenocarcinoma (AAC), have been stable or decreasing in most populations, the researchers said. "The reason for the ... Read more

Related support groups: Cancer, Colorectal Cancer, Human Papilloma Virus, Anal Fissure and Fistula, Condylomata Acuminata, Anal Itching, Gardasil, Human Papillomavirus Vaccine, Cervarix, Cervical Dysplasia, Human Papillomavirus Prophylaxis, Gardasil 9

Kids 14 and Younger Only Need 2 HPV Vaccine Shots: CDC

Posted 20 Oct 2016 by Drugs.com

THURSDAY, Oct. 20, 2016 – Children 14 and younger require only two doses of the HPV vaccine rather than the previously recommended three shots, U.S. health officials now say. The vaccine protects against infection with sexually transmitted HPV (human papillomavirus), which can cause cervical and other cancers. On Wednesday, the Centers for Disease Control and Prevention recommended that 11- to 12-year-olds receive two doses of HPV vaccine at least six months apart. It also said teens 13 and 14 can be vaccinated on the two-dose schedule. However, those who start receiving the vaccinations later – at ages 15 to 26 – still need three doses of the vaccine, according to the updated guidelines. One cervical cancer expert called the new guidelines "very important." "Decreasing the number of shots from three to two will definitely increase the chances of compliance [with vaccination]," said ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervarix, Human Papillomavirus Vaccine, Cervical Dysplasia, Vaccination and Prophlaxis, Gardasil 9

Are Fewer Cervical Cancer Screenings Needed After HPV Vaccine?

Posted 18 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Women who've been vaccinated against human papillomavirus (HPV) likely need fewer cervical cancer screenings, a new study argues. Just how often a woman needs a cervical cancer screening depends on the type of vaccine she had, the researchers said. Women vaccinated with earlier versions of the HPV vaccine – which protect against the two worst cancer-causing strains of the sexually transmitted virus – only need cervical cancer screening every five years starting at age 25 or 30, the study concluded. Women who've received the updated vaccine, which protects against seven cancer-causing strains of HPV, need screening even less often. The researchers recommend testing these women every 10 years starting at age 30 to 35 and ending at age 65. Both screening regimens would be much less rigorous than current guidelines, which call for cervical cancer exams from age 21 ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

A Doctor's Words Key to Whether Child Gets HPV Vaccine

Posted 2 Oct 2016 by Drugs.com

FRIDAY, Sept. 30, 2016 – The language doctors use when recommending the human papillomavirus (HPV) vaccine can influence whether parents will have their children immunized, a new study finds. HPV causes most cases of cervical cancer and a large percentage of vaginal, vulvar, anal, penile and oropharyngeal cancers. The U.S. Centers for Disease Control and Prevention recommends boys and girls receive the three-dose HPV vaccination beginning at age 11 or 12. As of 2015, only 42 percent of girls and 28 percent of boys ages 13 to 17 had completed the HPV vaccine series, according to the CDC. Previous research found that doctors' recommendations play a major role in whether parents have their children vaccinated. In this new study, researchers examined if specific language used by doctors affects parents' decisions. The study included more than 1,500 parents. Their children were between the ... Read more

Related support groups: Cancer, Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Head and Neck Cancer, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

Cancer Experts Endorse CDC's HPV Vaccine Guidelines

Posted 19 Jul 2016 by Drugs.com

TUESDAY, July 19, 2016 – The American Cancer Society has endorsed the U.S. government's HPV vaccination recommendations, which include immunizing all preteens against the sexually transmitted human papilloma virus. In a new report, the cancer society says 11- and 12-year-old girls as well as boys should be vaccinated to guard against cancers associated with HPV. This is in line with updated guidelines from the federal Centers for Disease Control and Prevention. "HPV vaccination has the potential to prevent tens of thousands of cancers and hundreds of thousands of pre-cancers each year," said the lead author of the report, Debbie Saslow. She is the cancer society's director of cancer control intervention for HPV vaccination and women's cancers. "It is critical that all stakeholders – families, health care providers, and others – make HPV vaccination a priority, so that prevention of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Cervical Dysplasia, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9

HPV-Linked Cancers Still Climbing in U.S.

Posted 9 Jul 2016 by Drugs.com

THURSDAY, July 7, 2016 – Cancers linked to the sexually transmitted human papillomavirus (HPV) keep rising in the United States, even though most cases are preventable, health officials reported Thursday. Cervical cancer, and mouth and throat cancers in men, accounted for most of the nearly 39,000 HPV-associated cancers diagnosed annually from 2008 to 2012, according to the U.S. Centers for Disease Control and Prevention. HPV vaccination and cervical cancer screening could keep more than 28,000 of these cancers from developing, the agency estimated. "Most cervical cancers are preventable with regular screening for precancerous lesions among women aged 21 to 65 years, linked with follow-up for abnormal test results," the CDC researchers wrote in the report. But cancer experts said that public perception may have to change first, especially with respect to HPV vaccination. "In order to ... Read more

Related support groups: Condylomata Acuminata, Gardasil, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis, Vaccination and Prophlaxis, Gardasil 9, Haemophilus influenzae Prophylaxis

1st HPV Test for Use With Preservative Fluid

Posted 8 Jul 2016 by Drugs.com

FRIDAY, July 8, 2016 – The U.S. Food and Drug Administration has approved Roche's cobas HPV Test – the first diagnostic to be used with cervical cells obtained for a Pap test and collected in SurePath Preservative Fluid. SurePath is an FDA-approved liquid collection fluid that's frequently used for Pap tests. But until this latest approval, no human papillomavirus (HPV) test had been approved to be used with the fluid, the FDA said in a news release. HPV strains account for some 70 percent of cervical cancers globally. The U.S. National Cancer Institute estimates there will be nearly 13,000 new cases of cervical cancer detected this year, and the disease will cause more than 4,100 deaths. The Swiss drugmaker Roche in 2012 warned that using cervical cells in SurePath fluid with an existing HPV test could produce false-negative results, the FDA said. This could have led to lack of ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Diagnosis and Investigation, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

Too Few U.S. Teens Getting HPV Vaccine: CDC

Posted 30 Jul 2015 by Drugs.com

THURSDAY, July 30, 2015 – Most boys and a large portion of girls in the United States have not received even a single dose of the cancer-preventing human papillomavirus (HPV) vaccine, even though some slow progress has been made, federal researchers report. Four out of 10 girls and six out of 10 boys, aged 13 to 17, have not started the recommended HPV vaccine series, leaving them vulnerable to developing a wide array of cancers, according to the U.S. Centers for Disease Control and Prevention. Every year, about 27,000 women and men in the United States are diagnosed with a cancer caused by HPV infection, the CDC said. HPV vaccination could prevent the majority of these cancers from ever developing, said Dr. Anne Schuchat, assistant surgeon general and director of CDC's National Center for Immunization and Respiratory Diseases. Nearly all cervical and anal cancers are caused by HPV, ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis, Gardasil 9

College Kids Don't Understand the HPV Threat

Posted 5 Jun 2015 by Drugs.com

FRIDAY, June 5, 2015 – Many American college students don't get vaccinated against human papillomavirus (HPV), and many don't fully understand the threat posed by the virus or their risk for infection, new findings suggest. In women, some types of HPV – the most common sexually transmitted disease – can lead to cancers of the cervix, vulva, vagina and anus. In men, some types of HPV can lead to cancers of the anus and penis, according to the U.S. National Institutes of Health. Researchers surveyed 192 female undergraduate students at Oakland University in Michigan. The results showed that most of the respondents knew about the HPV vaccine, but 54 percent were not vaccinated. The findings were presented this week at the annual meeting of the American Society for Microbiology, in New Orleans. The data and conclusions of research presented at meetings should be viewed as preliminary ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis

HPV Vaccine Program in Australia Linked to Lower Infection Rates

Posted 8 Sep 2014 by Drugs.com

MONDAY, Sept. 8, 2014 – Improved access to the human papillomavirus (HPV) vaccine has resulted in a significant reduction in rates of genital warts among young women in Australia, a new study has found. HPV is a common, sexually transmitted virus that affects both women and men. In some cases, HPV can lead to cancer or genital warts. Since HPV usually doesn't cause symptoms, people may not even realize they're infected. The HPV vaccine can help prevent HPV-related cancers and other conditions. This vaccine is most effective when it's given before a person becomes sexually active, researchers have found. The HPV vaccine is being provided free in Australian schools as part of the country's national immunization program, the study authors noted. The vaccine protects against two major viral causes of genital warts – HPV 6 and 11. It also protects against two major viral causes of cervical ... Read more

Related support groups: Condylomata Acuminata, Cervical Cancer, Gardasil, Cervarix, Human Papillomavirus Vaccine, Human Papillomavirus Prophylaxis

Partial HPV Vaccine Series May Help Prevent Genital Warts in Girls

Posted 11 Feb 2014 by Drugs.com

TUESDAY, Feb. 11, 2014 – Girls given two doses of the human papillomavirus (HPV) vaccine instead of the recommended three doses appear to have some protection against genital warts, Swedish researchers report. Whether two doses is enough to protect against cervical cancer, however, isn't known and experts remain wary of partial vaccination since the primary goal of the vaccine is to protect women from this potentially deadly cancer. "This is the first study investigating the effectiveness of the HPV vaccine in the population by dose level," said lead researcher Lisen Arnheim-Dahlstrom, an associate professor in the department of medical epidemiology and biostatistics at the Karolinska Institute, in Stockholm. "It is important to bear in mind that we have been studying genital warts, which is the first measurable disease outcome that we can study after vaccination because of its short ... Read more

Related support groups: Condylomata Acuminata, Gardasil, Human Papillomavirus Vaccine, Cervarix, Human Papillomavirus Prophylaxis

Many Young Americans Know Little About Cervical Cancer Vaccine

Posted 9 Dec 2013 by Drugs.com

SATURDAY, Dec. 7 – Few people realize how effective the vaccines against HPV (human papillomavirus) are for preventing cervical cancer, and even fewer talk about the vaccine with their doctors, according to a survey of more than 1,400 people. "From previous research, we know people are generally aware of the vaccine," said Kassandra Alcaraz, director of health disparities research at the American Cancer Society, who led the study. "From this study, we learned that people are not sure it is effective." Alcaraz and her team used data from a U.S. National Cancer Institute (NCI) survey on health trends, collected in 2012 and 2013. Those who responded were either in the age range for which the vaccine is recommended or had an immediate family member in that age bracket. The U.S. Centers for Disease Control and Prevention recommends HPV vaccination for boys and girls at age 11 or 12, before ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis

HPV Vaccination Sends Genital Wart Cases Plummeting: Study

Posted 18 Apr 2013 by Drugs.com

THURSDAY, April 18 – In the five years since launching a nationwide human papillomavirus (HPV) vaccination program among girls between the ages of 12 and 26, Australia has seen a huge drop in the number of cases of genital warts, new research reveals. Among Australian girls in the targeted age range for vaccination, the country saw genital wart cases plummet by 59 percent within just the first two years of the program's launch in 2007. By aggressively vaccinating girls against HPV (which is responsible for 90 percent of genital wart diagnoses), Australia appears to have offered considerable protection not just to its female population but also its men as well. How? Researchers point to a phenomenon known as "herd immunity," whereby the immunity acquired by a certain segment of the population – in this case, women – ends up protecting an unvaccinated segment of the population (men). ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Gardasil, Cervarix, Human Papillomavirus Vaccine, Cervical Dysplasia, Human Papillomavirus Prophylaxis

Parents' Worries About HPV Vaccine on the Rise: Study

Posted 18 Mar 2013 by Drugs.com

MONDAY, March 18 – Although experts recommend girls and young women be vaccinated against the virus that causes most cases of cervical cancer, parents seem to be increasingly worried about the vaccine's safety, a new U.S. study shows. Experts say the findings are both worrying and puzzling, because the vaccine – which guards against the human papillomavirus (HPV) – has not been linked to any serious side effects. "It's really concerning that parents think the HPV vaccine isn't safe," said Dr. Dennis Cunningham, an infectious disease specialist at Nationwide Children's Hospital in Columbus, Ohio. Cunningham, who was not involved in the study, pointed out that about 12,000 U.S. women are diagnosed with cervical cancer each year. And most of those cases are linked to HPV infection. There are more than 100 strains of HPV, some of which cause genital and anal warts. In most people, the ... Read more

Related support groups: Human Papilloma Virus, Condylomata Acuminata, Cervical Cancer, Gardasil, Human Papillomavirus Vaccine, Cervical Dysplasia, Cervarix, Human Papillomavirus Prophylaxis

Page 1 2 Next

Ask a Question

Further Information

Related Condition Support Groups

Human Papilloma Virus

Related Drug Support Groups

Aldara, imiquimod, Zyclara, podofilox, interferon alfa-2b, echinacea, Condylox, Veregen, Intron A, interferon alfa-n3, sinecatechins, Alferon N